Zdrowie i gospodarka · 11/04/2024
FDA Clears VISTARIL Oral Suspension for Approval
The FDA has determined that VISTARIL Oral Suspension, 25mg/5mL, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of generic versions.